Role of 18F-FDG PET/CT in Assessment of Recurrence and Metastases in Female Breast Carcinoma Patients in Relation to Immunohistochemical Markers: Emphasis on HER2 Status, SUVmax Correlation, and Alignment with 2025/2026 EANM/SNMMI Guidelines. Bangladesh J. Nuclear Med. [Internet]. 2026 May 19 [cited 2026 Jun. 29];29(1):28-35. Available from: https://banglajol.info/index.php/BJNM/article/view/89278